Mgr. Andrea Knight, Ph.D.
Assistant professor, Martin Piskáček Group: Transcription in Malignant Cells and Immunity
Office: bldg. C03/317
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 5331 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 50
2024
-
Harnessing the EphA2 blockade in glioblastoma
Year: 2024, type:
2023
-
Blockade of PD-L1 and B7-H3 checkpoint inhibitor ligands in glioblastoma
Year: 2023, type: Conference abstract
-
Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia
Cancer immunology, immunotherapy, year: 2023, volume: 72, edition: 5, DOI
-
Gamma-delta T cells in patients with endometriosis
Year: 2023, type:
-
Targeting undruggable oncoproteins c-Myc and N-Myc by the 9aaTADs
Year: 2023, type: Appeared in Conference without Proceedings
-
The NFkB activation domain is 14-amino-acid-long variant of the 9aaTAD
The Biochemical journal, year: 2023, volume: 480, edition: 5, DOI
2022
-
CMV-reactive Vdelta1 gd T cells are equally cytotoxic to CMV-specific ab T cells in HLA-A*02 healthy donors
Year: 2022, type: Conference abstract
-
Cryptic inhibitory regions nearby activation domains
Biochimie, year: 2022, volume: 200, edition: September 2022, DOI
-
Plasma levels of immune checkpoint inhibitor ligands PD-L1, B7-H3 and galectin-9 in glioblastoma patients
Year: 2022, type: Conference abstract
-
Tumor infiltration of gamma-delta T cells in glioblastoma
Year: 2022, type: Conference abstract